PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.
about
Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer XenograftsA regulatory feedback loop between HIF-1α and PIM2 in HepG2 cellsMicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma.The PIM family of serine/threonine kinases in cancer.PIM kinases: an overview in tumors and recent advances in pancreatic cancer.Pim kinases in hematological malignancies: where are we now and where are we going?The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma.Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas.Pim-2 Modulates Aerobic Glycolysis and Energy Production during the Development of Colorectal TumorsCXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival.Expression of the CXCR4 ligand SDF-1/CXCL12 is prognostically important for adenocarcinoma and large cell carcinoma of the lung.Effects of arsenic sulfide (As2S2) on B and T lymphoma cell lines and possible underlying mechanisms.Prognostic relevance of protein expression, clinical factors, and MYD88 mutation in primary bone lymphoma.CXCR4-SERINE339 regulates cellular adhesion, retention and mobilization, and is a marker for poor prognosis in acute myeloid leukemia.Phenotype profiling of primary testicular diffuse large B-cell lymphomas.The role of G protein-coupled receptors in lymphoid malignancies.Analysis of Genomic Alteration in Primary Central Nervous System Lymphoma and the Expression of Some Related Genes
P2860
Q27304359-853A1EB9-F9A7-41F4-BCD5-D9E19CAF38AFQ35088674-8BDC2852-259B-4B85-9917-E49D426A09FEQ37098282-BC508332-C927-4B02-926E-F90D90112650Q38098139-457740FE-7E37-44B6-B636-96B9270F3303Q38209606-1DE8414D-585D-4F5F-8125-9A052C2C0238Q38285805-6DF5B81A-2AC5-4D87-8DB4-D39A3C2AA3CDQ38728157-165A1947-0E51-47BF-9CC0-ED62D18A1DA5Q38813901-DF0757CA-0CA2-4F4F-8AAE-A1DDDCAB27C1Q38863674-49F862A8-8637-4A9F-B843-79C928FD4D52Q38955569-248DD13A-476B-4EAC-8398-95293C6035D1Q40051508-2B0C35D2-0D16-4A6D-8D04-CC99C4CDA78BQ41928769-984E0398-B24B-4398-83C1-BCE6F1AFB4F9Q42371562-371AEF6D-D92D-4F6C-BA53-4E9B9F00EB3AQ45990007-6EB52376-F477-408C-A7B1-BD71EA108F9CQ47769320-2E13EB75-64AF-41A6-B309-743D8650AECCQ47960121-0C7B4E3E-04C4-4CC9-A10E-F8FCF5AC2555Q58737485-52A5B349-C32A-4C30-A9A6-3A77E3F15ACF
P2860
PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PIM kinases are progression ma ...... diffuse large B-cell lymphoma.
@ast
PIM kinases are progression ma ...... diffuse large B-cell lymphoma.
@en
type
label
PIM kinases are progression ma ...... diffuse large B-cell lymphoma.
@ast
PIM kinases are progression ma ...... diffuse large B-cell lymphoma.
@en
prefLabel
PIM kinases are progression ma ...... diffuse large B-cell lymphoma.
@ast
PIM kinases are progression ma ...... diffuse large B-cell lymphoma.
@en
P2093
P2860
P356
P1476
PIM kinases are progression ma ...... diffuse large B-cell lymphoma
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2012.272
P407
P577
2012-06-21T00:00:00Z